Literature DB >> 26309608

Auxiliary diagnostic value of monocyte chemoattractant protein-1 of whole blood in active tuberculosis.

Ying Wang1, Hang Li2, Hong Bao1, Yufen Jin1, Xiaoju Liu1, Xueqiong Wu3, Ting Yu1.   

Abstract

The aim of this study was to study the expression level of interferon-γ (IFN-γ) and monocyte chemoattractant protein-1 (MCP-1) in peripheral blood and its auxiliary diagnostic value in active tuberculosis. A chemiluminescence enzyme immunoassay method was used to detect the levels of IFN-γ and MCP-1 in peripheral blood. Then the receiver operating characteristic curve were drawn to determine the threshold of IFN-γ and MCP-1 for diagnosis of active tuberculosis and to evaluate their diagnostic performance. The specific IFN-γ and MCP-1 levels in the active tuberculosis group were significantly higher than those in the non-tuberculous pulmonary disease group (P < 0.01) and those in the healthy control group (P < 0.01). The IFN-γ levels in the healthy control group and the non-tuberculous respiratory disease group showed no statistically significant difference (P > 0.05), but the MCP-1 levels in the non-tuberculous respiratory disease group were significantly higher than those of the healthy control group (P < 0.05). The specific IFN-γ and MCP-1 level cut off values were 256 pg/ml and 389 pg/ml as an active tuberculosis diagnostic standard. The sensitivities of IFN-γ and MCP-1 were 57.3% and 92.8%, respectively; specificities were 80% and 80.7%, respectively; the positive predictive values were 76.9% and 84.9%, respectively; negative predictive values were 61.7% and 78.7%, respectively; and accuracy rates were 76.9% and 84.9%, respectively. Compared with the detection of IFN-γ, we observed a better diagnostic performance of MCP-1 in peripheral blood in active tuberculosis. MCP-1 may become one of the active tuberculosis auxiliary diagnostic targets.

Entities:  

Keywords:  IFN-γ; Tuberculosis; diagnosis; monocyte chemoattractant protein-1

Year:  2015        PMID: 26309608      PMCID: PMC4537985     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

Review 1.  New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.

Authors:  Madhukar Pai; Shriprakash Kalantri; Keertan Dheda
Journal:  Expert Rev Mol Diagn       Date:  2006-05       Impact factor: 5.225

2.  Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.

Authors:  Jussi J Saukkonen; Beth Bazydlo; Michael Thomas; Robert M Strieter; Joseph Keane; Hardy Kornfeld
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guérin.

Authors:  Carmen Penido; Adriana Vieira-de-Abreu; Marcelo T Bozza; Hugo C Castro-Faria-Neto; Patrícia T Bozza
Journal:  J Immunol       Date:  2003-12-15       Impact factor: 5.422

4.  Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.

Authors:  Malathesha Ganachari; Jorge A Ruiz-Morales; Juan C Gomez de la Torre Pretell; Jeffrey Dinh; Julio Granados; Pedro O Flores-Villanueva
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

Review 5.  In vivo properties of monocyte chemoattractant protein-1.

Authors:  L Gu; B Rutledge; J Fiorillo; C Ernst; I Grewal; R Flavell; R Gladue; B Rollins
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

6.  Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis.

Authors:  M Ruhwald; T Bodmer; C Maier; M Jepsen; M B Haaland; J Eugen-Olsen; P Ravn
Journal:  Eur Respir J       Date:  2008-08-06       Impact factor: 16.671

7.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 8.  QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?

Authors:  Tom G Connell; Molebogeng X Rangaka; Nigel Curtis; Robert J Wilkinson
Journal:  Expert Rev Mol Diagn       Date:  2006-09       Impact factor: 5.225

9.  Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.

Authors:  Kathryn L Kellar; Jennifer Gehrke; Stephen E Weis; Aida Mahmutovic-Mayhew; Blachy Davila; Margan J Zajdowicz; Robin Scarborough; Philip A LoBue; Alfred A Lardizabal; Charles L Daley; Randall R Reves; John Bernardo; Brandon H Campbell; William C Whitworth; Gerald H Mazurek
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

10.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.